Lenka Pleštilová

565 total citations
23 papers, 420 citations indexed

About

Lenka Pleštilová is a scholar working on Epidemiology, Immunology and Rheumatology. According to data from OpenAlex, Lenka Pleštilová has authored 23 papers receiving a total of 420 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 9 papers in Immunology and 8 papers in Rheumatology. Recurrent topics in Lenka Pleštilová's work include Inflammatory Myopathies and Dermatomyositis (15 papers), Rheumatoid Arthritis Research and Therapies (7 papers) and Immunodeficiency and Autoimmune Disorders (6 papers). Lenka Pleštilová is often cited by papers focused on Inflammatory Myopathies and Dermatomyositis (15 papers), Rheumatoid Arthritis Research and Therapies (7 papers) and Immunodeficiency and Autoimmune Disorders (6 papers). Lenka Pleštilová collaborates with scholars based in Czechia, United Kingdom and Sweden. Lenka Pleštilová's co-authors include Jiří Vencovský, H. Mann, Ladislav Šenolt, Ondřej Pecha, Lucie Andrés Cerezo, Martin Klein, Karel Pavelká, Neil McHugh, Zoë Betteridge and Josef Zámečnı́k and has published in prestigious journals such as PLoS ONE, Annals of the Rheumatic Diseases and Lara D. Veeken.

In The Last Decade

Lenka Pleštilová

23 papers receiving 406 citations

Peers

Lenka Pleštilová
Lenka Pleštilová
Citations per year, relative to Lenka Pleštilová Lenka Pleštilová (= 1×) peers Levente Bodoki

Countries citing papers authored by Lenka Pleštilová

Since Specialization
Citations

This map shows the geographic impact of Lenka Pleštilová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lenka Pleštilová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lenka Pleštilová more than expected).

Fields of papers citing papers by Lenka Pleštilová

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lenka Pleštilová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lenka Pleštilová. The network helps show where Lenka Pleštilová may publish in the future.

Co-authorship network of co-authors of Lenka Pleštilová

This figure shows the co-authorship network connecting the top 25 collaborators of Lenka Pleštilová. A scholar is included among the top collaborators of Lenka Pleštilová based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lenka Pleštilová. Lenka Pleštilová is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pleštilová, Lenka, Olga Kryštůfková, Dana Tegzová, et al.. (2017). Molecular markers of systemic autoimmune disorders: the expression of MHC-located HSP70 genes is significantly associated with autoimmunity development.. PubMed. 35(1). 33–42. 16 indexed citations
2.
Pleštilová, Lenka, Michel Neidhart, Giancarlo Russo, et al.. (2016). Expression and Regulation of PIWIL-Proteins and PIWI-Interacting RNAs in Rheumatoid Arthritis. PLoS ONE. 11(11). e0166920–e0166920. 25 indexed citations
3.
Ekholm, Louise, Saskia Vosslamber, Anna Tjärnlund, et al.. (2016). Autoantibody Specificities and Type I Interferon Pathway Activation in Idiopathic Inflammatory Myopathies. Scandinavian Journal of Immunology. 84(2). 100–109. 28 indexed citations
4.
Klein, Martin, H. Mann, Lenka Pleštilová, et al.. (2015). Increasing incidence of immune-mediated necrotizing myopathy: single-centre experience. Lara D. Veeken. 54(11). 2010–2014. 51 indexed citations
5.
Herbert, Megan K., Judith Stammen‐Vogelzangs, Marcel M. Verbeek, et al.. (2015). Disease specificity of autoantibodies to cytosolic 5′-nucleotidase 1A in sporadic inclusion body myositis versus known autoimmune diseases. Annals of the Rheumatic Diseases. 75(4). 696–701. 108 indexed citations
6.
Klein, Martin, H. Mann, Lenka Pleštilová, et al.. (2014). Arthritis in Idiopathic Inflammatory Myopathy: Clinical Features and Autoantibody Associations. The Journal of Rheumatology. 41(6). 1133–1139. 19 indexed citations
7.
Mann, H., Hana Hulejová, Ondřej Pecha, et al.. (2014). Decreased Circulating Visfatin Is Associated with Improved Disease Activity in Early Rheumatoid Arthritis: Data from the PERAC Cohort. PLoS ONE. 9(7). e103495–e103495. 23 indexed citations
8.
Pleštilová, Lenka, et al.. (2014). A3.29 Micro-RNA molecules are clearly involved in pathogenesis of idiopathic inflammatory myopathy. Annals of the Rheumatic Diseases. 73. A53–A54. 1 indexed citations
9.
Šenolt, Ladislav, Lucie Andrés Cerezo, Barbora Šumová, et al.. (2014). High levels of metastasis-inducing S100A4 protein and treatment outcome in early rheumatoid arthritis: data from the PERAC cohort. Biomarkers. 20(1). 47–51. 13 indexed citations
10.
Pleštilová, Lenka, H. Mann, Lucie Andrés Cerezo, et al.. (2014). The metastasis promoting protein S100A4 levels associate with disease activity rather than cancer development in patients with idiopathic inflammatory myopathies. Arthritis Research & Therapy. 16(5). 468–468. 14 indexed citations
11.
Mann, H., Hana Hulejová, Ondřej Pecha, et al.. (2014). Decrease in Serum Interleukin-21 Levels Is Associated With Disease Activity Improvement in Patients With Recent-Onset Rheumatoid Arthritis. Physiological Research. 63(4). 475–481. 17 indexed citations
12.
Pleštilová, Lenka, et al.. (2014). A3.30 Plasma level of HSP70 protein is increased in czech patients with idiopathic inflammatory myopathy. Annals of the Rheumatic Diseases. 73. A54–A54. 2 indexed citations
13.
Hulejová, Hana, H. Mann, Ondřej Pecha, et al.. (2014). THU0528 Decrease in Circulating Visfatin Levels is Associated with Disease Activity Improvement in Early Rheumatoid Arthritis. Annals of the Rheumatic Diseases. 73. 366–366. 1 indexed citations
14.
Klein, Martin, H. Mann, Petra Hánová, et al.. (2013). SAT0188 Clinical and Ultrasonographic Characteristics of Arthritis in Patients with Idiopathic Inflammatory Myopathies. Annals of the Rheumatic Diseases. 72. A644–A645. 1 indexed citations
15.
Pleštilová, Lenka, Hana Hulejová, Ondřej Pecha, et al.. (2013). A7.11 Genetic Variation in Promoter Sequence of B-Cell-Activating Factor of the TNF Family (BAFF) in Patients with Idiopathic Inflammatory Myopathies (IIM). Annals of the Rheumatic Diseases. 72. A51–A52. 2 indexed citations
16.
Pleštilová, Lenka, et al.. (2013). A7.24 The Pentanucleotide Insertion in HSPA1B Gene is Associated with Idiopathic Inflammatory Myopathy. Annals of the Rheumatic Diseases. 72. A56–A56. 1 indexed citations
17.
Tansley, Sarah, Zoë Betteridge, Harsha Gunawardena, et al.. (2012). Clinical Differences Between Adult and Juvenile Dermatomyositis Associated with Anti-NXP2 Autoantibodies.. UCL Discovery (University College London). 1 indexed citations
18.
Filková, Mária, Hana Hulejová, Lenka Pleštilová, et al.. (2012). Resistin in idiopathic inflammatory myopathies. Arthritis Research & Therapy. 14(3). R111–R111. 25 indexed citations
19.
Pleštilová, Lenka, Karina Gheorghe, Ingrid E. Lundberg, et al.. (2012). THU0253 ANTI-PM-SCL autoantibodies in polymyositis and dermatomyositis. Annals of the Rheumatic Diseases. 71. 240–240. 2 indexed citations
20.
Cerezo, Lucie Andrés, H. Mann, Ondřej Pecha, et al.. (2011). Decreases in serum levels of S100A8/9 (calprotectin) correlate with improvements in total swollen joint count in patients with recent-onset rheumatoid arthritis. Arthritis Research & Therapy. 13(4). R122–R122. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026